Ido Wolf
Impact in
- Nephrology top 1%
- Parathyroid Disorders and Treatments
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 58
- Cancer Immunotherapy and Biomarkers 13
- Pancreatic and Hepatic Oncology Research 9
- Lung Cancer Research Studies 7
-
- Metabolism, Diabetes, and Cancer 10
- Co-authors
- Tamar Rubinek (41 shared papers)Bella Kaufman (16 shared papers)Hagai Ligumsky (10 shared papers)Raphael Catane (9 shared papers)Hannah Kanety (8 shared papers)Beth Y. Karlan (7 shared papers)H. Phillip Koeffler (7 shared papers)Avraham Karasik (3 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Oncogene (8 papers)The Oncologist (7 papers)Cancer Research (7 papers)Breast Cancer Research and Treatment (6 papers)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ido Wolf
148 papers receiving 4.4k citations
Ido Wolf's Hit Papers
Peers
Comparison fields: 5 of 124
- Nephrology 624
- Oncology 1.2k
- Cancer Research 543
- Health Informatics 42
- Reproductive Medicine 224
Countries citing papers authored by Ido Wolf
This map shows the geographic impact of Ido Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ido Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ido Wolf more than expected).
Fields of papers citing papers by Ido Wolf
This network shows the impact of papers produced by Ido Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ido Wolf. The network helps show where Ido Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside Ido Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cyclophosphamide Triggers Follicle Activation and “Burnout”; AS101 Prevents Follicle Loss and Preserves Fertility Hit paper breakdown → | 2013 | 428 |
| 2 | 2005 | 335 | |
| 3 | 2013 | 302 | |
| 4 | 2008 | 259 | |
| 5 | 2006 | 178 | |
| 6 | 2006 | 158 | |
| 7 | 2021 | 122 | |
| 8 | 2011 | 110 | |
| 9 | 2021 | 93 | |
| 10 | 2021 | 93 | |
| 11 | 2011 | 93 | |
| 12 | 2011 | 90 | |
| 13 | 2007 | 90 | |
| 14 | 2006 | 89 | |
| 15 | 2021 | 83 | |
| 16 | 2024 | 72 | |
| 17 | 2014 | 72 | |
| 18 | 2018 | 72 | |
| 19 | 2007 | 66 | |
| 20 | 2016 | 61 |
About Ido Wolf
Ido Wolf is a scholar working on Oncology, Molecular Biology, Genetics, Nephrology and Cancer Research, having authored 165 papers that have together received 4.5k indexed citations. Recurring topics across this work include Parathyroid Disorders and Treatments (22 papers), Genetic Syndromes and Imprinting (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Metabolism, Diabetes, and Cancer (10 papers), Pancreatic and Hepatic Oncology Research (9 papers), Cannabis and Cannabinoid Research (7 papers), Estrogen and related hormone effects (7 papers) and Lung Cancer Research Studies (7 papers). The work is most often cited by research in Nephrology (624 citations), Oncology (1.2k citations), Cancer Research (543 citations), Health Informatics (42 citations) and Reproductive Medicine (224 citations). Ido Wolf has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Tamar Rubinek, Bella Kaufman, Hagai Ligumsky, Raphael Catane, Hannah Kanety, Beth Y. Karlan, H. Phillip Koeffler, Avraham Karasik, Barliz Waissengrin and Siegal Sadetzki. Their work appears in journals such as Journal of Clinical Oncology, Oncogene, The Oncologist, Cancer Research and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.